Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Ravinet, Aurelie

Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire. [electronic resource] - Transplantation Aug 2016 - 1732-9 p. digital

Publication Type: Comparative Study; Journal Article

1534-6080

10.1097/TP.0000000000000976 doi


Adolescent
Adult
Antilymphocyte Serum--adverse effects
Bone Marrow Transplantation--methods
Busulfan--therapeutic use
Chi-Square Distribution
Chronic Disease
Cyclophosphamide--therapeutic use
Disease-Free Survival
Dose Fractionation, Radiation
Female
France
Graft vs Host Disease--immunology
HLA Antigens--immunology
Histocompatibility
Histocompatibility Testing
Humans
Immunosuppressive Agents--adverse effects
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute--diagnosis
Male
Middle Aged
Multivariate Analysis
Myeloablative Agonists--therapeutic use
Myelodysplastic Syndromes--diagnosis
Peripheral Blood Stem Cell Transplantation--adverse effects
Proportional Hazards Models
Recurrence
Retrospective Studies
Risk Factors
Time Factors
Transplantation Conditioning--adverse effects
Treatment Outcome
Unrelated Donors
Whole-Body Irradiation
Young Adult